Andere talen Ginkgo Bioworks Holdings, Inc.

Aandelen

DNA

US37611X1000

Beurs gesloten - Nyse Andere beurzen 22:00:02 25-04-2024			Voorbeurs 13:00:17
0,7777 ^USD	-8,05%		0,79	+1,58%

16/04	Il Granaio delle Idee en Ginkgo Bioworks kondigen een strategische samenwerking aan om zuurdesemstammen te optimaliseren voor bakkerijproducten	CI
11/04	Transcript : Ginkgo Bioworks Holdings, Inc. Presents at Ginkgo's Annual Ferment Conference 2024, Apr-11-2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Global Retail Giant Enhances Warehouse Efficiency with Vuzix (VUZI) Smart Glasses Rollout	24/04
Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products	16/04
Il Granaio delle Idee and Ginkgo Bioworks Announces Strategic Collaboration to Optimize Sourdough Strains for Bakery Products	16/04
Modalis Announces Partnership with Ginkgo Bioworks	15/04
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces 'Lab Data as a Service'	12/04
Ginkgo Bioworks Acquires AgBiome's Platform Assets	11/04
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets	11/04
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"	11/04
Ginkgo Bioworks Expands Research Partnership With Novo Nordisk	10/04
Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain	10/04
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks	10/04
Ginkgo Bioworks Partners With IdeeLab Biotechnology in Brazil	08/04
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service	08/04
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service	08/04
Ginkgo Bioworks to Host 5th Annual Ferment Conference	04/04
Ginkgo Bioworks, Prozomix Collaborate on Enzyme Development	03/04
Ginkgo Bioworks Acquires Modulus Therapeutics Cell Therapy Assets to Strengthen Next-Gen CAR Designs	03/04
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing	03/04
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing	03/04
Ginkgo Bioworks (NYSE: DNA) completed the acquisition of cell therapy platform assets of Modulus Therapeutics.	02/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ginkgo Bioworks Holdings, Inc.

Aandelen

DNA

US37611X1000

Andere talen

Filters